PRTN3 and rheumatoid arthritis: Despite numerous previous demonstrations on associations between calprotectin and disease activity and severity in RA, we still lack a deeper understanding how of calprotectin relates to inflammation in patients with and without the autoantibodies used in RA classification: IgM RF and ACPA, which could potentially be useful for designing individualized therapies.